Altoida
Founded 2016 · 29 employees on LinkedIn · 12 known investors
Find your way into Altoida
Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease. It serves healthcare providers and pharmaceutical companies for cognitive diagnostics, clinical trial enrichment, and disease progression research in the neurological care field.
Investors · 12
How we know: Alpana Ventures's portfolio page · a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
How we know: Daniel Gutenberg's portfolio page · Not right? Tell us
How we know: Hikma Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: M Ventures's portfolio page · a partner's Signal profile · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: Polytech Ecosystem Ventures's portfolio page · Not right? Tell us
How we know: VI Partners's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: Whitecap Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$6.3M disclosed across 1 of 4 rounds · 2019–2022
- Undisclosed amountSeries AMar 2022Source ↗
- Undisclosed amountseries AJun 2019Source ↗
- $6.3MSeries AMay 2019 · 3 sources
M Ventures (lead), Alpana Ventures, FYRFLY Venture Partners, Grey Sky Venture Partners, VI Partners AG
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
4 people who came through Altoida went on to found or lead other companies.
In the news
Frequently asked questions
- What does Altoida do?
- Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease. It serves healthcare providers and pharmaceutical companies for cognitive diagnostics, clinical trial enrichment, and disease progression research in the neurological care field.
- Who are Altoida's investors?
- Altoida's investors include Alpana Ventures, Daniel Gutenberg, Eisai Innovation, Inc., Hikma Ventures, M Ventures, Polytech Ecosystem Ventures, VI Partners, Whitecap Venture Partners and 2 more.
- How much funding has Altoida raised?
- Altoida has disclosed $6.3M raised across 1 of its 4 known rounds.









